| __timestamp | Insmed Incorporated | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 56292000 | 1271353000 |
| Thursday, January 1, 2015 | 74277000 | 1620577000 |
| Friday, January 1, 2016 | 122721000 | 2052295000 |
| Sunday, January 1, 2017 | 109749000 | 2075142000 |
| Monday, January 1, 2018 | 145283000 | 2186100000 |
| Tuesday, January 1, 2019 | 131711000 | 3036600000 |
| Wednesday, January 1, 2020 | 181157000 | 2735000000 |
| Friday, January 1, 2021 | 272744000 | 2908100000 |
| Saturday, January 1, 2022 | 397518000 | 3592500000 |
| Sunday, January 1, 2023 | 571011000 | 4439000000 |
| Monday, January 1, 2024 | 5132000000 |
Unleashing the power of data
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Regeneron Pharmaceuticals, Inc. and Insmed Incorporated have been at the forefront of this race. Since 2014, Regeneron has consistently outpaced Insmed, with its R&D expenses growing by approximately 250%, reaching a staggering $4.4 billion in 2023. In contrast, Insmed's R&D spending, while impressive, has increased by about 900% over the same period, peaking at $571 million in 2023. This significant investment underscores both companies' dedication to advancing medical science and developing groundbreaking therapies. As the biotech industry continues to evolve, these financial commitments highlight the strategic priorities of each company and their potential impact on future healthcare innovations.
AstraZeneca PLC or Insmed Incorporated: Who Invests More in Innovation?
R&D Spending Showdown: Regeneron Pharmaceuticals, Inc. vs Viatris Inc.
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Insmed Incorporated
Regeneron Pharmaceuticals, Inc. or Jazz Pharmaceuticals plc: Who Invests More in Innovation?
R&D Insights: How Regeneron Pharmaceuticals, Inc. and PTC Therapeutics, Inc. Allocate Funds
Comparing Innovation Spending: Regeneron Pharmaceuticals, Inc. and Dynavax Technologies Corporation
Research and Development: Comparing Key Metrics for argenx SE and Insmed Incorporated
Insmed Incorporated vs Opthea Limited: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Insmed Incorporated vs Alpine Immune Sciences, Inc.
Insmed Incorporated vs Taro Pharmaceutical Industries Ltd.: Strategic Focus on R&D Spending
Insmed Incorporated vs Travere Therapeutics, Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Insmed Incorporated vs Viridian Therapeutics, Inc.